TLR9 signalling activation via direct ligation and its functional consequences in CD4 + T cells

Area of Science:

• Immunology
• Molecular Biology

Background:

• CpG Oligodeoxynucleotides (ODNs) are known Toll-like receptor 9 (TLR9) ligands.
• Previous studies suggested CD4+ T cell responses to ODNs are independent of TLR9 and MyD88.

Purpose of the Study:

• To investigate the interaction between ODN 2216 and TLR9 in human CD4+ T cells.
• To assess the impact of this interaction on TLR9 signaling and CD4+ T cell phenotype.

Main Methods:

• Studied ligand-receptor interactions of ODN 2216 and TLR9 in human CD4+ T cells.
• Assessed TLR9 signaling, MyD88 independence, TGF-β expression, and cell phenotype.
• Evaluated the suppressive capacity of ODN 2216-treated CD4+ T cells.

Main Results:

• ODN 2216 uptake is TLR9-controlled and enhances TLR9 signaling molecules via feedback.
• ODN 2216 induces a TLR9-dependent, MyD88-independent increase in TGF-β expression.
• ODN 2216-treated CD4+ T cells exhibit an anti-inflammatory, Th3-like regulatory phenotype.
• These Th3-like cells suppress the proliferation of untreated CD4+ T cells.

Conclusions:

• There is a direct, interdependent relationship between ODN 2216 uptake and TLR9 signaling in CD4+ T cells.
• This study reveals a novel mechanism for modulating adaptive immunity using innate immune ligands.
• Findings support exploring direct immune cell modulation to control exaggerated inflammatory responses.